Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study

…, TE Fingerlin, JM Oldham, B Guillen-Guio… - The Lancet respiratory …, 2017 - thelancet.com
Background Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with
high mortality, uncertain cause, and few treatment options. Studies have identified a significant …

Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis

RJ Allen, B Guillen-Guio, JM Oldham… - American journal of …, 2020 - atsjournals.org
Rationale: Idiopathic pulmonary fibrosis (IPF) is a complex lung disease characterized by
scarring of the lung that is believed to result from an atypical response to injury of the …

Residual lung abnormalities after COVID-19 hospitalization: interim analysis of the UKILD post–COVID-19 study

I Stewart, J Jacob, PM George… - American journal of …, 2023 - atsjournals.org
Rationale: Shared symptoms and genetic architecture between coronavirus disease (COVID-19)
and lung fibrosis suggest severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…

Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis

RJ Allen, A Stockwell, JM Oldham, B Guillen-Guio… - Thorax, 2022 - thorax.bmj.com
Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition with poor survival times. We
previously published a genome-wide meta-analysis of IPF risk across three studies with …

Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study

…, DA Jenkins, OC Leavy, B Guillen-Guio… - The Lancet …, 2023 - thelancet.com
Background Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease characterised by
progressive scarring leading to alveolar stiffness, reduced lung capacity, and impeded gas …

[PDF][PDF] Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics

…, AD Stockwell, OC Leavy, JM Oldham, B Guillen-Guio… - Cell genomics, 2022 - cell.com
The research of rare and devastating orphan diseases, such as idiopathic pulmonary
fibrosis (IPF) has been limited by the rarity of the disease itself. The prognosis is poor—the …

Genetic overlap between idiopathic pulmonary fibrosis and COVID-19

RJ Allen, B Guillen-Guio, E Croot… - European …, 2022 - Eur Respiratory Soc
Coronavirus disease 2019 (COVID-19) is an infectious disease potentially leading to long-lasting
respiratory symptoms and has resulted in over 4 million deaths worldwide. Idiopathic …

Sepsis-associated acute respiratory distress syndrome in individuals of European ancestry: a genome-wide association study

B Guillen-Guio, JM Lorenzo-Salazar, SF Ma… - The Lancet …, 2020 - thelancet.com
Background Acute respiratory distress syndrome (ARDS) is a lung inflammatory process
caused mainly by sepsis. Most previous studies that identified genetic risks for ARDS focused …

Apoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and …

MC Estañ, E Calviño, S Calvo, B Guillén-Guío… - PloS one, 2014 - journals.plos.org
Fatty acid synthesis and oxidation are frequently exacerbated in leukemia cells, and may
therefore represent a target for therapeutic intervention. In this work we analyzed the apoptotic …

Genomics and the acute respiratory distress syndrome: current and future directions

T Hernández-Beeftink, B Guillen-Guio, J Villar… - International journal of …, 2019 - mdpi.com
The excessive hospital mortality associated with acute respiratory distress syndrome (ARDS)
in adults mandates an urgent need for developing new therapies and tools for the early risk …